Lineage Cell Therapeutics
LCTX
#8126
Rank
C$0.47 B
Marketcap
C$1.92
Share price
3.85%
Change (1 day)
39.51%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -C$28.69 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$10.81 Million. In 2024 the company made an earning of -C$30.5 Million, an increase over its 2023 earnings that were of -C$35.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$28.69 Million-5.93%
2024 -C$30.5 Million-13.16%
2023 -C$35.12 Million9.83%
2022 -C$31.98 Million-54.24%
2021 -C$69.87 Million86.07%
2020 -C$37.55 Million-31.97%
2019 -C$55.2 Million-5.42%
2018 -C$58.36 Million1.1%
2017 -C$57.73 Million-31.06%
2016 -C$83.73 Million-10.38%
2015 -C$93.43 Million29.69%
2014 -C$72.05 Million31.68%
2013 -C$54.71 Million
2011 -C$26.55 Million89.78%
2010 -C$13.99 Million206.06%
2009 -C$4.58 Million-0.58%
2008 -C$4.6 Million164.89%
2007 -C$1.74 Million-30.22%
2006 -C$2.49 Million
2002 -C$2.89 Million-41.04%
2001 -C$4.9 Million-32.04%
2000 -C$7.21 Million-11.85%
1999 -C$8.18 Million
1997 -C$5.26 Million12.12%
1996 -C$4.69 Million106.25%
1995 -C$2.28 Million-11.11%
1994 -C$2.56 Million50%
1993 -C$1.71 Million20%
1992 -C$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 603.03%๐Ÿ‡บ๐Ÿ‡ธ USA